CheckmAb is a company created to develop monoclonal antibodies against Treg cells present in diseased tissues as tools for safer and efficacious immunotherapies against cancer and autoimmune diseases
CheckmAb is a company created to develop monoclonal antibodies against Treg cells present in diseased tissues as tools for safer and efficacious immunotherapies against cancer and autoimmune diseases.